Validation of blocking TSP4/Cava2d1 interaction as a new target for neuropathic pain
$79,881R01FY2021DENIH
University Of California-Irvine, Irvine CA
Investigators
Linked publications, trials & patents
Abstract
Supplement Project Abstract Statement It is included with the supplement research plan
View original record on NIH RePORTER →